Also trades as: NEU.AX (ASX) · $vol 8M
NURPF OTC
Neuren Pharmaceuticals Limited
1W: +2.4%
1M: -12.1%
3M: +19.0%
YTD: +10.6%
1Y: +19.0%
3Y: +62.8%
5Y: +1313.9%
$14.28
+0.34 (+2.42%)
Weekly Expected Move ±6.0%
$13
$13
$14
$15
$16
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$290M
Revenue
+7.2% YoY
$169M
Net Income
-1.8% YoY
$143M
Free Cash Flow
-17.9% YoY
100.0%
Gross Margin
8.2%
Op. Margin
14.6%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE61.3%
ROA59.6%
ROIC282.5%
Valuation
P/E128.1
P/B7.7
EV/EBITDA0.0
Leverage
Debt/Equity0.00
Current Ratio46.45
Interest Cov.0.0x
Quality Scores
Piotroski F5/9
Altman Z—
Beneish M23.70